Literature summary for 3.4.15.1 extracted from

Hernandez, A.A.; Moreso, F.; Bayes, B.; Lauzurica, R.; Sanz-Guajardo, D.; Gomez-Huertas, E.; Pereira, P.; Paul, J.; Crespo, J.; Amenabar, J.J.; Oliver, J.; Seron, D.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain (2010), NDT plus, 3, ii21-ii25.

Search for more literature for 3.4.15.1

Application

Application	Comment	Organism
medicine	angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers decrease cardiovascular mortality and slow the progression of renal disease in non-transplant patients. Their impact on kidney transplant is associated with a better graft survival, overview	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	4842 adult renal transplantation patients from Spain of different operation years	-

Source Tissue

Source Tissue	Comment	Organism	Textmining

Synonyms

Synonyms	Comment	Organism
ACE	-	Homo sapiens
angiotensin-converting enzyme	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)